Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma
1996

Prognostic Value of MIB-1 in Gastric Carcinoma

Sample size: 418 publication Evidence: low

Author Information

Author(s): W Muller, A Schneiders, S Meier, G Hommel, HE Gabbert

Primary Institution: Institute of Pathology, Heinrich-Heine-University, Dusseldorf

Hypothesis

Does the immunohistochemical evaluation of MIB-1 expression correlate with the prognosis of gastric cancer patients?

Conclusion

The study found that MIB-1 expression does not have predictive value for the prognosis of gastric cancer patients.

Supporting Evidence

  • High proliferation indices were found in intestinal-type gastric carcinomas compared to diffuse-type.
  • No significant correlation was found between proliferation indices and survival rates.
  • Proliferation at the invasion front correlated with blood and lymphatic vessel invasion.

Takeaway

This study looked at how fast cancer cells grow in stomach cancer and found that it doesn't help predict how well patients will do.

Methodology

The study analyzed MIB-1 expression in 418 gastric carcinoma patients using immunohistochemistry and assessed correlations with various clinical parameters.

Potential Biases

Potential bias due to the exclusion of patients who died shortly after surgery and the retrospective nature of the study.

Limitations

The study was retrospective and had a significant loss to follow-up (21% of patients).

Participant Demographics

The study included 418 patients, with a mean age of 64.9 years, consisting of 327 males (61.8%) and 202 females (38.2%).

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication